Form 4 for EBS Emergent BioSolutions Inc.
Accepted 2025-08-13 00:00:00 ET · period of report 2025-08-12 · accession 0001628280-25-040156 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-13 | 2025-08-12 | EBS | DeGolyer Donald W | Dir | S - Sale | $8.65 | -7,844 | 137.7K | -5% | -$67.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-12 | S | D | 7,844 | $8.65 | 137,659 | D | — | — | (F1) Represents the number of shares sold by the Reporting Person to satisfy the Reporting Person's tax obligations resulting from the settlement of vested RSUs on May 22, 2025. (F2) All shares sold at an exact price of $8.6475. |